Agilent Technologies Balance Sheet Health
Financial Health criteria checks 5/6
Agilent Technologies has a total shareholder equity of $6.4B and total debt of $3.4B, which brings its debt-to-equity ratio to 53.5%. Its total assets and total liabilities are $12.2B and $5.9B respectively. Agilent Technologies's EBIT is $1.6B making its interest coverage ratio 32.3. It has cash and short-term investments of $1.5B.
Key information
53.52%
Debt to equity ratio
US$3.41b
Debt
| Interest coverage ratio | 32.3x |
| Cash | US$1.54b |
| Equity | US$6.37b |
| Total liabilities | US$5.86b |
| Total assets | US$12.23b |
Recent financial health updates
Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?
May 02
Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?
Jan 22Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly
Oct 21Recent updates
Agilent: Growth Across All Segments, But Investors Will Need To Be Patient
Aug 28Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Aug 03What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?
Jul 01Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?
May 02City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto
Apr 24Tariffs And Tactics: Agilent's Path Through Trade Disruption
Apr 07Agilent Technologies: Recent Price Weakness Makes This Stock A Buy
Mar 01Getting In Cheap On Agilent Technologies, Inc. (NYSE:A) Is Unlikely
Feb 24A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Feb 07Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?
Jan 22Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?
Dec 13Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report
Nov 28Agilent Q4: Expecting Market Recovery In 2025
Nov 26Agilent Technologies' (NYSE:A) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 26Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly
Oct 21
Strategic Expansion And Digital Innovation Poised To Catapult Growth In Life Sciences
Strategic acquisitions and innovation in biopharma and environmental testing highlight a focus on high-demand areas and regulatory changes, suggesting potential revenue growth.Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi
Aug 23Agilent: Making A Move To Ignite Some Growth
Jul 25Is Agilent A Buy Before Earnings? Examining The Pros And Cons
May 23Financial Position Analysis
Short Term Liabilities: A's short term assets ($4.3B) exceed its short term liabilities ($1.9B).
Long Term Liabilities: A's short term assets ($4.3B) exceed its long term liabilities ($4.0B).
Debt to Equity History and Analysis
Debt Level: A's net debt to equity ratio (29.4%) is considered satisfactory.
Reducing Debt: A's debt to equity ratio has increased from 46.6% to 53.5% over the past 5 years.
Debt Coverage: A's debt is well covered by operating cash flow (43.9%).
Interest Coverage: A's interest payments on its debt are well covered by EBIT (32.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/06 09:28 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/07/31 |
| Annual Earnings | 2024/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Agilent Technologies, Inc. is covered by 44 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Francis Mainwaring | Atlantic Equities LLP |
| Catherine Ramsey Schulte | Baird |
| Ishan Majumdar | Baptista Research |